Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Assumes Surgery Partners at Neutral, Announces Price Target of $27

Author: Benzinga Newsdesk | September 18, 2025 07:04am
JP Morgan analyst Benjamin Rossi assumes Surgery Partners (NASDAQ:SGRY) with a Neutral rating and announces Price Target of $27.

Posted In: SGRY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist